NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

Description: Founded in 1981, BioReference Laboratories is a clinical testing laboratory offering a comprehensive menu of services tapped by health care providers interested in the detection, ...

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) executed a Restitution Agreement with John Littleton, a former vice president in sales. Pursuant to the Agreement ...

BioReference® Health LLC, an OPKO Health, Inc. company and a trusted provider of diagnostic testing in the United States, today announced the launch of BioReference DirectTM, a new digital health ...

Similar to BioReference's role as the testing provider for the MLS is Back Tournament, BioReference is providing laboratory-based PCR COVID-19 testing as well as point-of-care (rapid) COVID-19 testing ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So What: ...

Scarlet brings diagnostic service to patients' homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers ...

ELMWOOD PARK, N.J., Aug. 16, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S ...

The Web cast will be archived, on both Web sites, for 30 days following the call. About Bio-Reference Laboratories, Inc. The Company is the largest independent regional clinical laboratory in the ...

ELMWOOD PARK, N.J.--(BUSINESS WIRE)-- CEO Marc Grodman M.D. of Bio-Reference Laboratories, Inc. (BRLI) (NASDAQ – BRLI) was one of the key panelists at a November 17 bi-partisan policy forum in ...

BioReference Health, formerly known as BioReference Laboratories, and OPKO Health have agreed to pay $9.85 million to resolve alleged violations of the False Claims Act arising from BioReference’s ...